Data from an Israeli project shows higher proportion of insecurely attached infants in center care as compared with noncenter care (Sagi, Koren-Karie, Gini, Ziv, & Joels, 2002). The present study was designed to assess structural and emotional aspects characterizing infants' experiences in center care, aiming to explain, in part, the high incidence of attachment insecurity among center-care infants. In the present study, we focus on 151 center-care infants who were observed in the Ainsworth Strange Situation (Ainsworth, Blehar, Waters, & Wall, 1978) with their mothers. Sixty-one percent of them were coded as securely attached to their mothers while 39% were coded as insecurely attached. In addition, 56 directors and 120 caregivers in 56 centers were videotaped throughout a full-day observation. The Assessment Profile of Early Childhood Program (Abbott-Shim & Sibley, 1987) was also employed. Results indicated that the centers in Israel are of low standards: Large group size, high caregiver-infants ratio, inadequate professional training, and minimal attention to individual emotional needs. No associations were found between infants' attachment and various aspects of the settings. The low quality of the Israeli settings may explain the higher rate of attachment insecurity in center-care infants. ©2005 Michigan Association for Infant Mental Health.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/imhj.20039 | DOI Listing |
Mol Pharm
January 2025
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Microneedles (MNs) are emerging as versatile tools for both therapeutic drug delivery and diagnostic monitoring. Unlike hypodermic needles, MNs achieve these applications with minimal or no pain and customizable designs, making them suitable for personalized medicine. Understanding the key design parameters and the challenges during contact with biofluids is crucial to optimizing their use across applications.
View Article and Find Full Text PDFSci Adv
January 2025
College of Chemistry, Fuzhou University, Fuzhou 350116, China.
The angiopoietin (Ang)-Tie axis, critical for endothelial cell function and vascular development, is a promising therapeutic target for treating vascular disorders and inflammatory conditions like sepsis. This study aimed to enhance the binding affinity of recombinant Ang1 variants to the Tie2 and explore their therapeutic potential. Structural insights from the Ang1-Tie2 complex enabled the identification of key residues within the Ang1 receptor binding domain (RBD) critical for Tie2 interaction.
View Article and Find Full Text PDFHypertension
February 2025
Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.M.K., L.N., S.P.J.).
AIDS
January 2025
Botswana Harvard Health Partnership, 1836 Northring Road, Gaborone, Botswana.
Objective: To evaluate the impact of ART duration and CD4 count on risk for high grade cervical dysplasia in women with HIV (WWH) compared to women without HIV in the treat-all era with integrase strand inhibitors (INSTIs).
Design: Prospective longitudinal cohort study in Botswana.
Methods: From February 2021 to August 2022, baseline HPV self-sampling was offered to women with and without HIV.
Inflamm Bowel Dis
January 2025
Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petach Tikva 4920235, Israel.
Background And Aims: Patients with very early-onset inflammatory bowel disease (VEO-IBD), with an age of onset < 6 years, can present with severe manifestations and may require biologic therapy. Infliximab and adalimumab are approved for induction and maintenance in pediatric IBD patients but are licensed only above the age of 6 years. Effectiveness and safety data on adalimumab in this patient population are lacking.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!